Effective management of cardiogenic shock (CS) is hampered by a lack of evidence-based
information. This is a high-mortality condition, without clear, evidence-based guidelines
for perioperative management, specifically-a lack of target endpoints for treatment
(e.g.: mean arterial pressure or oxygenation), utility of regional care systems or
the benefits of palliative care.
The Acute Cardiovascular Care Association (ACCA) of the European Society of Cardiology
(ESC) recently published a position statement that aimed to offer contemporary guidance
on the diagnosis and treatment of acute myocardial infarction (AMI) complicated by
CS. Herein, we review this complex clinical topic and review the ACCA statement on
AMI associated with CS, with a focus on relevance to perioperative management.
Key Words
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of Cardiothoracic and Vascular AnesthesiaAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Management of cardiogenic shock in a cardiac intensive care unit.Methodist Debakey Cardiovasc J. 2020; 16: 36-42
- Cardiogenic shock: Failure of oxygen delivery and oxygen utilization.Clin Cardiol. 2016; 39: 477-483
- Cardiogenic shock in acute myocardial infarction: The era of mechanical support.J Am Coll Cardiol. 2016; 67: 1881-1884
- Fourth universal definition of myocardial infarction.Circulation. 2018; 138: e618-e651
- Mechanisms of plaque formation and rupture.Circ Res. 2014; 114: 1852-1866
- Structural changes in myocardium during acute ischemia.Circ Res. 1974; 35: 156-172
- Correlation of antemortem serum creatine kinase, creatine kinase-MB, troponin I, and troponin T with cardiac pathology.Clin Chem. 2000; 46: 338-344
- Contemporary management of cardiogenic shock: A scientific statement from the American Heart Association.Circulation. 2017; 136: e232-e268
- Acute Cardiovascular Care Association position statement for the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock: A document of the Acute Cardiovascular Care Association of the European Society of Cardiology.Eur Heart J Acute Cardiovasc Care. 2020; 9: 183-197
- Management of cardiogenic shock complicating acute myocardial infarction: A review.Clin Cardiol. 2019; 42: 484-493
- Role of inducible nitric oxide synthase in the reduced responsiveness of the myocardium to catecholamines in a hyperdynamic, murine model of septic shock.Crit Care Med. 2006; 34: 307-313
- LINCS: L-NAME (a NO synthase inhibitor) in the treatment of refractory cardiogenic shock: A prospective randomized study.Eur Heart J. 2003; 24: 1287-1295
- The nitric oxide pathway and oxidative stress in heart failure.Congest Heart Fail. 2002; 8 (142-7,155)
- Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: The COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial.Circulation. 2003; 108: 1184-1190
- Interleukin-6, -7, -8 and -10 predict outcome in acute myocardial infarction complicated by cardiogenic shock.Clin Res Cardiol. 2012; 101: 375-384
- Systemic inflammatory response syndrome after acute myocardial infarction complicated by cardiogenic shock.Arch Intern Med. 2005; 165: 1643-1650
- Current spectrum of cardiogenic shock and effect of early revascularization on mortality. Results of an International Registry. SHOCK Registry Investigators.Circulation. 1995; 91: 873-881
- Cardiogenic shock complicating acute myocardial infarction—etiologies, management and outcome: A report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?.J Am Coll Cardiol. 2000; 36: 1063-1070
- Epidemiology, pathophysiology and contemporary management of cardiogenic shock - a position statement from the Heart Failure Association of the European Society of Cardiology.Eur J Heart Fail. 2020; 22: 1315-1341
- SCAI clinical expert consensus statement on the classification of cardiogenic shock: This document was endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), the Society of Critical Care Medicine (SCCM), and the Society of Thoracic Surgeons (STS) in April 2019.Catheter Cardiovasc Interv. 2019; 94: 29-37
- Intraaortic balloon support for myocardial infarction with cardiogenic shock.N Engl J Med. 2012; 367: 1287-1296
- Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.N Engl J Med. 1999; 341: 625-634
- Restrictive physiology in cardiogenic shock: Observations from echocardiography.Am Heart J. 2006; 151 (890 e899-15)
- A review of cardiogenic shock in acute myocardial infarction.Curr Cardiol Rev. 2008; 4: 34-40
- Mechanical circulatory support devices for acute right ventricular failure.Circulation. 2017; 136: 314-326
- Cardiogenic shock caused by right ventricular infarction: A report from the SHOCK registry.J Am Coll Cardiol. 2003; 41: 1273-1279
- The nomenclature, definition and distinction of types of shock.Dtsch Arztebl Int. 2018; 115: 757-768
- Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction.JAMA. 2006; 295: 2511-2515
- Percutaneous coronary intervention or coronary artery bypass surgery for cardiogenic shock and multivessel coronary artery disease?.Am Heart J. 2010; 159: 141-147
- PCI strategies in patients with acute myocardial infarction and cardiogenic shock.N Engl J Med. 2017; 377: 2419-2432
- Routine upfront abciximab versus standard periprocedural therapy in patients undergoing primary percutaneous coronary intervention for cardiogenic shock: The PRAGUE-7 study. An open randomized multicentre study.Acute Card Care. 2011; 13: 116-122
- 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC).Eur Heart J. 2018; 39: 119-177
- 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: The task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.Eur J Heart Fail. 2016; 18: 891-975
- Incidence and outcomes associated with early heart failure pharmacotherapy in patients with ongoing cardiogenic shock.Crit Care Med. 2014; 42: 281-288
- Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia.N Engl J Med. 2002; 346: 557-563
- Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest.N Engl J Med. 2002; 346: 549-556
- Targeted temperature management for cardiac arrest with nonshockable rhythm.N Engl J Med. 2019; 381: 2327-2337
- Mild hypothermia in cardiogenic shock complicating myocardial infarction.Circulation. 2019; 139: 448-457
- Comparison of dopamine and norepinephrine in the treatment of shock.N Engl J Med. 2010; 362: 779-789
- Epinephrine versus norepinephrine for cardiogenic shock after acute myocardial infarction.J Am Coll Cardiol. 2018; 72: 173-182
- Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): Final 12 month results of a randomised, open-label trial.Lancet. 2013; 382: 1638-1645
- Intraaortic balloon pump in cardiogenic shock complicating acute myocardial infarction: Long-term 6-year outcome of the randomized IABP-SHOCK II trial.Circulation. 2018 Nov 11; ([E-pub ahead of print]Accessed September 1, 2020)https://doi.org/10.1161/CIRCULATIONAHA.118.038201
- Percutaneous short-term active mechanical support devices in cardiogenic shock: A systematic review and collaborative meta-analysis of randomized trials.Eur Heart J. 2017; 38: 3523-3531
- The use of a durable right ventricular assist device for isolated right ventricular failure due to combined pre- and postcapillary pulmonary hypertension.Pulm Circ. 2019; 92045894019831222
- Changes in hospital mortality rates in 425 patients with acute ST-elevation myocardial infarction and cardiac rupture over a 30-year period.Circulation. 2008; 118: 2783-2789
- Surgical repair of ventricular septal defect after myocardial infarction: Outcomes from the Society of Thoracic Surgeons National Database.Ann Thorac Surg. 2012; 94 (discussion 443-4): 436-443
- Interventional post-myocardial infarction ventricular septal defect closure: A systematic review of current evidence.EuroIntervention. 2016; 12: 94-102
- Clinical outcome after surgical correction of mitral regurgitation due to papillary muscle rupture.Circulation. 2008; 118: 1528-1534
Article info
Publication history
Published online: November 04, 2020
Identification
Copyright
© 2020 Elsevier Inc. All rights reserved.
